ZoomMed inc. (TSX VENTURE: ZMD). Mr. Yves Marmet, President and Chief Executive Officer announce an amendment to the stock option plan of the Corporation.
The shareholders of the Corporation approved a resolution modifying of the stock option plan from a 10% "fixed" stock option plan to a 10% "rolling" stock option plan as described in the management proxy circular for the annual and special meeting of shareholders held October 27, 2006.
However, the modification of the stock option plan is subject to the approval of the TSX Venture Exchange.
ZoomMed has developed a new electronic tool, aiming at changing the way drugs are prescribed and dispensed throughout Canada. The "ZRx Prescriber" allows a doctor to fill out and electronically send prescription information to pharmacists, allowing them to view this information on-line and to confirm it with the signed prescription. This user friendly Web product, designed for doctors, uses the latest "Pocket Pc" technologies.
For more information on ZOOMMED or the "ZRx Prescriber", please visit our website: www.zoommed.com.
The TSX Venture Exchange does not assume any responsibility as for the relevance or with the exactitude of this press release.
President and Chief Executive Officer
450-678-5457 ext 228